☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search category
Search here
Search here
Subscribe Now
All Posts by Date
Bristol-Myers's Opdivo (nivolumab) Receives FDA Priority Review for 2L+ Patients with SCLC in ~20 yrs
August 17, 2018
Eisai and Merck Annouces the US FDA Approval of Lenvima for Unresectable 1L Hepatocellular Carcinoma (HCC)
August 17, 2018
Nordisk Acquires Ziylo's Glucose Binding Platform to Expand its Glucose Responsive Insulins
August 17, 2018
Load more...
Back to Home
Stay Connected
LinkedIn
Twitter
Facebook
instagram
Youtube
Join the PharmaShots family of 12000+ subscribers
Newsletter
Subscribe Now
I accept the
Terms and Conditions